-+ 0.00%
-+ 0.00%
-+ 0.00%

BTIG Reiterates Buy on Bioage Labs, Maintains $40 Price Target

Benzinga·09/08/2026 15:25:16
语音播报
BTIG analyst Thomas Shrader reiterates Bioage Labs (NASDAQ:BIOA) with a Buy and maintains $40 price target.